Robin Turner, general manager of Roche Czech Republic, shares how he transformed the affiliate from a “local” company to a highly engaged member of the Roche group whilst breaking down the obstacles to introducing innovative therapies and making personalized medicine a reality in the Czech Republic. Turner sees the increased involvement of patients in the decision-making process as the most positive development in the last three years and shares the initiatives Roche is putting in place to empower and support patients.
My mission was to rebuild and transform the organization from a “local” company to a highly engaged member of the global Roche group
